Monkeypox cases are rising. Should we be worried?

The World Health Organization has said the current outbreak of monkeypox is the largest ever recorded outside sub-Saharan Africa, with cases rising above the 100-mark a few days ago and the

J&J ducks out of Bavarian Nordic vaccine partnerships

Johnson & Johnson has halved the size of its collaboration with Bavarian Nordic on vaccine development, jettisoning its stake in shots targeting human papillomavirus (HPV) and hepatitis

Trailing its RSV vaccine rivals, Bavarian Nordic cuts China ...

Bavarian Nordic has licensed rights to its respiratory syncytial virus (RSV) vaccine in China and certain other Asian markets to Shanghai's Nuance Pharma in a $225 million deal.

J&J's Ebola vaccine approved in EU

The European Commission has approved Johnson & Johnson's Ebola vaccine, developed by its Janssen pharmaceuticals unit and Bavarian Nordic.

GSK completes travel vaccine offload as revamp continues

GSK sells travel vaccines to Bavarian Nordic

GlaxoSmithKline (GSK) has sold off two travel vaccines to Bavarian Nordic, as the company shifts its focus away from drugs it acquired through a multi-billion “asset swap” deal with Novarti